The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Showing 1-13 of 13 articles
Coronary interventions
EffectivenesS of additional x-ray PRotection dEviceS in reducing Scattered radiation in radial interventiOn: the ESPRESSO randomized trial
Anadol R, Brandt M, Merz N, Knorr M, Ahoopai M, Geyer M, Krompiec D, Wenzel P, Münzel T, Gori T
April 28, 2020 | 10.4244/EIJ-D-19-00945
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier A, Buono A, Serruys P, Sabate M
March 20, 2020 | 10.4244/EIJ-D-19-00773
Interventions for valvular disease
Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants
von Bardeleben R, Hobohm L, Kreidel F, Ostad MA, Schulz E, Konstantinides S, Lankeit M, Feldman T, Münzel T, Keller K
April 16, 2019 | 10.4244/EIJ-D-18-00961
Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds: three-year follow-up in a cohort of consecutive patients
Anadol R, Lorenz L, Weissner M, Ullrich H, Polimeni A, Münzel T, Gori T
October 12, 2018 | 10.4244/EIJ-D-17-00410
Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)
Nef H, Wiebe J, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm C
December 20, 2017 | 10.4244/EIJ-D-17-00330
Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R
Mehilli J, Achenbach S, Wöhrle J, Baquet M, Riemer T, Münzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C, Wöhrle J, Richardt G
December 20, 2017 | 10.4244/EIJ-D-17-00291
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabate M, Tamburino C, Nef H, Gori T
October 11, 2017 | 10.4244/EIJ-D-16-00568
Coronary interventions
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabate M, Tamburino C, Brugaletta S
April 20, 2017 | 10.4244/EIJ-D-16-00974
Coronary interventions
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras S, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabate M, Mattesini A, Geraci S, Naber C, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T
August 5, 2016 | 10.4244/EIJY15M09_10
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C
February 20, 2015 | 10.4244/EIJY14M07_11
Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes
Gori T, Schulz E, Hink U, Wenzel P, Post F, Jabs A, Münzel T
January 20, 2014 | 10.4244/EIJV9I9A176
The impact of gender on fractional flow reserve measurements
Fineschi M, Guerrieri G, Orphal D, Palmerini E, Münzel T, Warnholtz A, Pierli C, Gori T
July 26, 2013 | 10.4244/EIJV9I3A58
How should I treat a patient with typical angina, typical angiography, negative FFR?
Jabs A, Hink U, Fineschi M, Münzel T, Gori T
May 21, 2013 | 10.4244/EIJV9I1A22

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Device entrapment in chronic total occlusions
September 30, 2020
Editorial
Complex PCI: time for a universal definition
Joanna J. Wykrzykowska
September 30, 2020
JAA
This Week's JAA's: Impact of neoatherosclerosis in ISR on clinical outcome...
September 29, 2020
Spyral, Popular-Tavi, Sort out IX, Solve TAVI, and more
(Released thanks to the support of Biotronik)
September 30, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke